Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics
Fecha de publicación:
Fecha Ahead of Print:
Autores de IDIVAL
Unidades
Abstract
Nanoencapsulation has become a recent advancement in drug delivery, enhancing stability, bioavailability, and enabling controlled, targeted substance delivery to specific cells or tissues. However, traditional nanoparticle delivery faces challenges such as a short circulation time and immune recognition. To tackle these issues, cell membrane-coated nanoparticles have been suggested as a practical alternative. The production process involves three main stages: cell lysis and membrane fragmentation, membrane isolation, and nanoparticle coating. Cell membranes are typically fragmented using hypotonic lysis with homogenization or sonication. Subsequent membrane fragments are isolated through multiple centrifugation steps. Coating nanoparticles can be achieved through extrusion, sonication, or a combination of both methods. Notably, this analysis reveals the absence of a universally applicable method for nanoparticle coating, as the three stages differ significantly in their procedures. This review explores current developments and approaches to cell membrane-coated nanoparticles, highlighting their potential as an effective alternative for targeted drug delivery and various therapeutic applications.
Datos de la publicación
- ISSN/ISSNe:
- 1661-6596, 1422-0067
- Tipo:
- Review
- Páginas:
- -
- DOI:
- 10.3390/ijms25042071
- PubMed:
- 38396747
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES MDPI AG
Citas Recibidas en Web of Science: 29
Documentos
- No hay documentos
Filiaciones
Keywords
- nanomedicine; biomimicry; biomimetic nanoparticle; targeted drug delivery; homotypic targeting; nanoparticle coating
Campos de Estudio
Financiación
Proyectos asociados
Diseño de un nano-biosensor para el cribado y detección rápida del cáncer de cabeza-cuello
Investigador Principal: Mónica López Fanarraga
PI22/00030 . INSTITUTO DE SALUD CARLOS III. . 2023
Nuevos nanoportadores dirigidos para el tratamiento y el seguimiento de la metástasis
Investigador Principal: LORENA GARCÍA HEVIA
PI23/00261 . INSTITUTO DE SALUD CARLOS III. . 2024
Actividad Investigadora